No Data
No Data
Bronco B, SE H&I, Good Product Plan, etc.
<4503> Astellas Pharma fell sharply by 55 to 1642. Jefferies Securities downgraded its investment rating from "buy" to "hold" and lowered its target stock price from 2100 yen to 1700 yen. Sales forecasts for overactive bladder treatment Mirabegron, hot flush treatment Veoza, and geographic atrophy treatment Izervay have been downwardly revised, and annual revenue estimates for the next five years are expected to decrease by an average of 5%. The EBITDA estimate appears to be about 9% below consensus. <7
Active and newly established stocks in the afternoon session.
Furuya Metal <7826> 4555 +135 fell below expectations, but the increase in dividends is valued. Kitanihon Seni <3409> 101 +3 signs sales contract with subsidiary of nasdaq-listed Medirom to sell the world's first smart tracker that does not require charging. AMAZIA <4424> 552 +80 expected increase in manga app usage due to the spread of COVID-19 and predictions of intense heat. FLN <9241> 1969 +219 saw an increase in interest due to the introduction of shareholder benefits on the previous day, and continues to be popular with buyers today.
Hot stocks digest (morning): Fuji Pharma, Bronco B, WOLVES, etc.
Furuya Metal <7826>: up 85 yen to 4505 yen. The company announced a downward revision of its financial estimates the previous day, with operating profit for the fiscal year ending June 24 decreasing 15.5% from the previous year's estimate to 9.7 billion yen from 10.2 billion yen. The delay in the sales recovery of the thin film division and the fine chemical recycling department is believed to be the reason. However, there were strong concerns about lower-than-expected results based on the situation until the third quarter, and the negative reaction was limited. On the other hand, with the implementation of a commemorative dividend of 30 yen, the annual dividend is expected to be 256 yen as previously forecasted.
Stocks that hit the daily limit up or down in the morning session.
■Cordia Therapeutics <194A>, WOLVES HAND <3409>, Kitanihon Spinning <4386>, SIG Group <4424>, AMAZIA <4935>, and LIBERTA all hit the limit up <190A>. ■Shin BioPharmaceuticals <4582> hit the limit down temporarily (including indicative values for limit up/down).
Hokkaido Textile - temporarily stopped rising, showing anticipation for development with Medirom Healthcare Technologies.
It rapidly rose to a temporary trading halt. MEDIROM MOTHER Labs, a subsidiary of Medirom Healthcare Technolog, announced that it has signed a sales contract for the world's first recharge-free smart tracker "MOTHER Bracelet" it developed. It also announced the start of negotiations for a strategic sales partnership with the Medirom group. It seems that in the case of conventional wearable devices, data loss due to battery depletion has been a problem. This will contribute to the growth of its healthcare business.
Volume change rate ranking (9:00 am) - Libomic, Yumiru link and other companies are ranked in.
*In volume change rate rankings, you can understand the interest of market participants, such as trending stocks, by comparing the volume for the most recent 5 days with the volume on the day of release. *Volume Change Rate Ranking Top [as of 9:32 on July 19] (Comparison with the most recent 5-day average volume): Stock Code and Name Volume 5-day Average Volume Volume Change Rate Stock Price Change Rate <7446> Tohoku Chemical 200 107185.08 400% 0% <3409> Kita-Nippon Bank
No Data